Local, Multicentre, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Patients With Diabetes Mellitus Type 2
Conditions: Diabetes Mellitus
Sponsor: Takeda

This may include, but is not limited to, redaction of the following: 


•
Title: Local, multicentre, observational, non-interventional prospective study of Alogliptin 
benzoate in patients with Diabetes mellitus type 2
NCT Number: NCT02756832
Protocol Approve Date: 19-Dec-2018
Certain information within this protocol has been redacted (ie, specific content is masked 
irreversibly from view with a black/blue bar) to protect either personally identifiable 
information or company confidential information. 
Named persons or organizations associated with the study.
Proprietary information, such as scales or coding systems, which are considered confidential 
information under prior agreements with license holder.
Other information as needed to protect confidentiality of Takeda or partners, personal
information, or to otherwise protect the integrity of the clinical study.

Personal Protected Data

Personal Protected Data
Personal Protected Data

Personal Protected Data

Personal Protected Data
Personal Protected Data

Personal Protected Data
Personal Protected Data
Personal Protected Data
Personal Protected Data

Personal Protected Data

Personal Protected Data
Personal Protected Data

Company Confidential Information

Company Confidential Information

Company Confidential Information

Company Confidential Information
Company Confidential Information
Company Confidential Information
Company Confidential Information
Company Confidential Information